Publication Addressing the Drug-Shortage Crisis in Oncology Patients with cancer face a crisis due to an ongoing shortage of essential chemotherapeutic drugs. Drug Choice Supply Chain
Publication Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019 Biosimilar uptake in the United States is limited. It has not been comprehensively studied in Medicare Advantage (MA).
Publication The Price Paradox of Biosimilar-Like Long-Acting Insulin Findings suggest that Basaglar was not less expensive for patients than Lantus. Empirical evaluation of biosimilar costs prior to automatic substitution is necessary. Health Economics